ATE491472T1 - Verfahren zur verringerung von depressionen durch hemmung der wirkung des kalziumkanals vom n-typ - Google Patents

Verfahren zur verringerung von depressionen durch hemmung der wirkung des kalziumkanals vom n-typ

Info

Publication number
ATE491472T1
ATE491472T1 AT03754219T AT03754219T ATE491472T1 AT E491472 T1 ATE491472 T1 AT E491472T1 AT 03754219 T AT03754219 T AT 03754219T AT 03754219 T AT03754219 T AT 03754219T AT E491472 T1 ATE491472 T1 AT E491472T1
Authority
AT
Austria
Prior art keywords
calcium channel
type calcium
inhibiting
effect
depression
Prior art date
Application number
AT03754219T
Other languages
German (de)
English (en)
Inventor
Hee-Sup Shin
Chanki Kim
Original Assignee
Korea Inst Sci & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Inst Sci & Tech filed Critical Korea Inst Sci & Tech
Application granted granted Critical
Publication of ATE491472T1 publication Critical patent/ATE491472T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03754219T 2002-10-17 2003-10-16 Verfahren zur verringerung von depressionen durch hemmung der wirkung des kalziumkanals vom n-typ ATE491472T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020063626A KR100873400B1 (ko) 2002-10-17 2002-10-17 Ｎ-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법
PCT/KR2003/002159 WO2004035087A1 (en) 2002-10-17 2003-10-16 Method for decreasing depression by inhibiting the activity of n-type calcium channel

Publications (1)

Publication Number Publication Date
ATE491472T1 true ATE491472T1 (de) 2011-01-15

Family

ID=36165421

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03754219T ATE491472T1 (de) 2002-10-17 2003-10-16 Verfahren zur verringerung von depressionen durch hemmung der wirkung des kalziumkanals vom n-typ

Country Status (8)

Country Link
US (1) US20060009444A1 (enExample)
EP (1) EP1558285B1 (enExample)
JP (1) JP2006509737A (enExample)
KR (1) KR100873400B1 (enExample)
AT (1) ATE491472T1 (enExample)
AU (1) AU2003273071A1 (enExample)
DE (1) DE60335406D1 (enExample)
WO (1) WO2004035087A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
KR101043519B1 (ko) * 2010-11-05 2011-06-23 (주)대우가구 등받이가 탄력을 가지는 의자
KR101101874B1 (ko) * 2011-09-29 2012-01-05 주식회사 코아스 틸팅용 프레임의자
WO2013083851A1 (en) * 2011-12-09 2013-06-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Screening assays for compounds for use in the treatment of stress-related disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use
EP0520200B1 (en) * 1991-06-24 1998-02-18 Neurosearch A/S Imidazole compounds, their preparation and use
JPH08217671A (ja) * 1995-02-15 1996-08-27 Sankyo Co Ltd Ｎ−（３−アシロキシアシル）グリシン誘導体
CA2336781C (en) * 1998-07-09 2010-12-14 Cv Technologies Inc. Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
KR20030061670A (ko) * 2002-01-15 2003-07-22 주식회사 바이오제노믹스 칼슘 이온 통로 알파１ｂ 유전자 변이 생쥐 및 그의제조방법

Also Published As

Publication number Publication date
DE60335406D1 (enExample) 2011-01-27
KR100873400B1 (ko) 2008-12-11
EP1558285A4 (en) 2006-04-26
US20060009444A1 (en) 2006-01-12
EP1558285A1 (en) 2005-08-03
WO2004035087A1 (en) 2004-04-29
AU2003273071A1 (en) 2004-05-04
KR20040034964A (ko) 2004-04-29
JP2006509737A (ja) 2006-03-23
EP1558285B1 (en) 2010-12-15

Similar Documents

Publication Publication Date Title
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
MY145081A (en) Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
SE0301010D0 (sv) Novel compounds
DK1311482T3 (da) Ikke-imidazolaryloxypiperidiner som H3-receptorligander
MY140710A (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
EA200700255A1 (ru) Новый карбамилированный еро и способ его получения
MXPA06011046A (es) Ciertos compuestos basados en triazol, composiciones, y usos de los mismos.
ATE485359T1 (de) Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche
EA201101240A1 (ru) Ингибиторы вируса гепатита с
TW200519089A (en) Biaryl sulfonamides and methods for using same
ATE460402T1 (de) Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1- rezeptors
TR200002940T2 (tr) Parazitlerin sebep olduğu hastalıkların papain süperfamilyasından sistein proteazların inhibisyonu yoluyla tedavisi
DE602006009652D1 (de) Eine herstellungsmethode von entacapon-enthaltenden granulaten für orale dosierformen
TW200519100A (en) Biaryl sulfonamides and methods for using same
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE60328816D1 (de) Prozess zur verminderung des acrylamidgehaltes von hitzebehandelten lebensmitteln
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
ATE443044T1 (de) Tace inhibitoren
DE60326248D1 (de) Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
DE60237521D1 (de) Verfahren zur hemmung der ethylenreaktionen von pflanzen
DE112005003750A5 (de) Verwendung von Moosen und/oder Flechten, Element und Verfahren zur Reduzierung des Feinstaubgehalts in der Luft
ATE448234T1 (de) Olanzapin-analoga und verfahren zu ihrer verwendung
DE602006019870D1 (de) Verfahren zur synthese von triazolen
DE60313886D1 (de) Zusammensetzung von einem ppar-alpha agonisten und metformin zur behandlung von obesitas
TW200716132A (en) Novel chemical compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties